Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on May 26, 2026

GUANGZHOU, China, May 26, 2026 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE:YSG), a leading China-based beauty group, today announced its unaudited financial results for the quarter ended March 31, 2026.

First Quarter 2026 Highlights

Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period.
Total net revenues from Skincare Brands^[1] for the first quarter increased by 58.5% to RMB574.2 million (US$83.2 million) from RMB362.4 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the first quarter of 2026 were 56.2%, as compared with 43.5% for the prior year period.
Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.
Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Non-GAAP net loss^[2] for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period.

Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "For the first quarter of 2026, we delivered top-line growth that met our previous guidance and demonstrated the ongoing resilience of our multi-brand strategy. Our growth this quarter was primarily propelled by the sustained upward momentum of our Skincare Brands, which experienced substantial year-over-year growth of 58.5%. Guided by our vision to become a world-class pioneer in beauty innovation, we remain committed to strengthening our R&D-led innovation, expanding our hero product families, and positioning our core brands for high-quality growth. Furthermore, we are pleased to note that we completed the first closing of our private placement of convertible notes and warrants in an aggregate principal amount equivalent to approximately US$120 million, with participation from Trustar Capital, Hillhouse and myself, on May 21, 2026. This successful closing serves as a powerful testament to our shareholders' long-term confidence in Yatsen's strategic direction and future value."

Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "Our financial results for the first quarter of 2026 reflect encouraging progress in the expansion of our core brands. Total net revenues from our Skincare Brands delivered robust growth, while the combined net revenues of our three major premium and clinical skincare brands, Galénic, DR.WU and Eve Lom, grew by 61.4% year over year. Our gross margin continued its year-over-year expansion and reached 80.2%. This underlying strength underscores the structural health of our business model. While we selectively deployed resources to scale and strengthen our core brands, our commitment to long-term profitability optimization remains unwavering. Moving forward, we are focused on cost optimization to ensure that our top-line expansion efficiently translates into future margin improvement."

First Quarter 2026 Financial Results

Net Revenues

Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. The increase was primarily due to a 58.5% year-over-year increase in net revenues from Skincare Brands, partially offset by a 5.0% year-over-year decrease in net revenues from Color Cosmetics Brands.^[3]

Gross Profit and Gross Margin

Gross profit for the first quarter of 2026 increased by 24.3% to RMB819.2 million (US$118.8 million) from RMB659.1 million for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.

Operating Expenses

Total operating expenses for the first quarter of 2026 increased by 32.5% to RMB918.1 million (US$133.1 million) from RMB693.2 million for the prior year period. As a percentage of total net revenues, total operating expenses for the first quarter of 2026 were 89.9%, as compared with 83.2% for the prior year period.

Fulfillment Expenses. Fulfillment expenses for the first quarter of 2026 were RMB61.1 million (US$8.9 million), as compared with RMB51.8 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the first quarter of 2026 decreased to 6.0% from 6.2% for the prior year period. The decrease was primarily due to further improvements in logistics efficiency.
Selling and Marketing Expenses. Selling and marketing expenses for the first quarter of 2026 were RMB737.2 million (US$106.9 million), as compared with RMB553.8 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the first quarter of 2026 increased to 72.2% from 66.4% for the prior year period. The increase was primarily driven by investments in broadening consumer awareness and building long-term brand equity of our core brands, coupled with higher traffic acquisition costs on the Douyin platform.
General and Administrative Expenses. General and administrative expenses for the first quarter of 2026 were RMB80.3 million (US$11.6 million), as compared with RMB64.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the first quarter of 2026 were 7.9% as compared with 7.8% for the prior year period, remaining largely flat.
Research and Development Expenses. Research and development expenses for the first quarter of 2026 were RMB39.4 million (US$5.7 million), as compared with RMB22.6 million for the prior year period. As a percentage of total net revenues, research and development expenses for the first quarter of 2026 increased to 3.9% from 2.7% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount.

Loss / Income from Operations

Loss from operations for the first quarter of 2026 was RMB99.0 million (US$14.3 million), as compared with RMB34.1 million for the prior year period. Operating loss margin was 9.7%, as compared with 4.1% for the prior year period.

Non-GAAP loss from operations^[4] for the first quarter of 2026 was RMB84.6 million (US$12.3 million), as compared with RMB14.9 million for the prior year period. Non-GAAP operating loss margin^[5] was 8.3%, as compared with 1.8% for the prior year period.

Net Loss / Income

Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Net loss margin was 6.1%, as compared with 0.7% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS^[6] for the first quarter of 2026 was RMB0.64 (US$0.09), as compared with RMB0.06 for the prior year period.

Non-GAAP net loss for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Non-GAAP net loss margin was 5.6%, as compared with non-GAAP net income margin of 0.9% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS^[7] for the first quarter of 2026 was RMB0.60 (US$0.09), as compared with non-GAAP net income attributable to Yatsen's ordinary shareholders per diluted ADS of RMB0.07 for the prior year period.

Balance Sheet and Cash Flow

As of March 31, 2026, the Company had cash, restricted cash and short-term investments of RMB934.2 million (US$135.4 million), as compared with RMB1.05 billion as of December 31, 2025.

Net cash used in operating activities for the first quarter of 2026 was RMB90.0 million (US$13.0 million), as compared with net cash generated from operating activities of RMB23.8 million for the prior year period.

Business Outlook

For the second quarter of 2026, the Company expects its total net revenues to be between RMB1.20 billion and RMB1.30 billion, representing a year-over-year increase of approximately 10% to 20%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.

Exchange Rate

This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.8980 to US$1.00, the exchange rate in effect as of March 31, 2026, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.

^[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.

^[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.

^[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.

^[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.

^[5] Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from operations as a percentage of total net revenues.

^[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.

^[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.

Conference Call Information

The Company's management will hold a conference call on Tuesday, May 26, 2026, at 7:30 A.M. U.S. Eastern Time or 7:30 P.M. Beijing Time to discuss its financial results and operating performance for the first quarter of 2026.

United States (toll free):	+1-888-346-8982
International:	+1-412-902-4272
Mainland China (toll free):	400-120-1203
Hong Kong, SAR (toll free):	800-905-945
Hong Kong, SAR:	+852-3018-4992

The replay will be accessible through Tuesday, June 2, by dialing the following numbers:

United States:						+1-855-669-9658
International:						+1-412-317-0088
Replay Access Code:						4359154

A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.

About Yatsen Holding Limited

Yatsen Holding Limited (NYSE:YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.

For more information, please visit http://ir.yatsenglobal.com.

Use of Non-GAAP Financial Measures

The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.

However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.

Safe Harbor Statement

This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Yatsen Holding Limited

Investor Relations

E-mail: ir@yatsenglobal.com

YATSEN HOLDING LIMITED
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(All amounts in thousands, except for share, per share data or otherwise noted)

	December 31,		March 31,		March 31,
	2025		2026		2026
	RMB'000		RMB'000		USD'000
Assets
Current assets
Cash and cash equivalents		765,379		876,144		127,014
Restricted Cash		42,117		58,036		8,413
Short-term investments		246,008		-		-
Accounts receivable, net		220,870		183,701		26,631
Inventories, net		508,730		573,339		83,117
Prepayments and other current assets		450,970		440,103		63,802
Amounts due from related parties		114		53		8
Total current assets		2,234,188		2,131,376		308,985
Non-current assets
Investments		653,560		667,995		96,839
Property and equipment, net		77,014		71,982		10,435
Goodwill, net		155,029		155,029		22,474
Intangible assets, net		537,509		509,249		73,826
Deferred tax assets		1,435		1,040		151
Right-of-use assets, net		173,915		158,718		23,009
Other non-current assets		14,332		22,151		3,211
Total non-current assets		1,612,794		1,586,164		229,945
Total assets		3,846,982		3,717,540		538,930
Liabilities, redeemable non-controlling interests and shareholders' equity
Current liabilities
Accounts and notes payable		149,371		154,805		22,442
Advances from customers		28,821		29,480		4,274
Accrued expenses and other liabilities		348,700		322,994		46,824
Amounts due to related parties		21,262		19,412		2,814
Income tax payables		13,690		13,778		1,997
Lease liabilities due within one year		53,435		53,039		7,689
Total current liabilities		615,279		593,508		86,040
Non-current liabilities
Deferred tax liabilities		107,906		106,052		15,374
Lease liabilities		123,157		110,184		15,973
Total non-current liabilities		231,063		216,236		31,347
Total liabilities		846,342		809,744		117,387
Redeemable non-controlling interests		1,337		1,337		194
Shareholders' equity
Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary shares authorized, comprising of 6,000,000,000 Class A ordinary shares, 960,852,606 Class B ordinary shares and 3,039,147,394 shares each of such classes to be designated as of December 31, 2025 and March 31, 2026; 2,096,600,883 Class A shares and 600,572,880 Class B ordinary shares issued as of December 31, 2025 and March 31, 2026; 1,276,663,163 Class A ordinary shares and 600,572,880 Class B ordinary shares outstanding as of December 31, 2025, 1,275,536,483 Class A ordinary shares and 600,572,880 Class B ordinary shares outstanding as of March 31, 2026)		173		173		25
Treasury shares		(1,250,678)		(1,253,378)		(181,702)
Additional paid-in capital		12,296,367		12,297,001		1,782,691
Statutory reserve		31,527		31,527		4,570
Accumulated deficit		(8,141,545)		(8,202,059)		(1,189,049)
Accumulated other comprehensive income		74,760		45,910		6,657
Total Yatsen Holding Limited shareholders' equity		3,010,604		2,919,174		423,192
Non-controlling interests		(11,301)		(12,715)		(1,843)
Total shareholders' equity		2,999,303		2,906,459		421,349
Total liabilities, redeemable non-controlling interests and shareholders' equity		3,846,982		3,717,540		538,930

YATSEN HOLDING LIMITED
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(All amounts in thousands, except for share, per share data or otherwise noted)

	For the Three Months Ended March 31,
	2025		2026		2026
	RMB'000		RMB'000		USD'000
Total net revenues		833,533		1,020,986		148,012
Total cost of revenues		(174,406)		(201,797)		(29,254)
Gross profit		659,127		819,189		118,758
Operating expenses:
Fulfilment expenses		(51,843)		(61,138)		(8,863)
Selling and marketing expenses		(553,815)		(737,236)		(106,877)
General and administrative expenses		(64,883)		(80,326)		(11,645)
Research and development expenses		(22,637)		(39,440)		(5,718)
Total operating expenses		(693,178)		(918,140)		(133,103)
Loss from operations		(34,051)		(98,951)		(14,345)
Financial income		10,606		10,741		1,557
Foreign currency exchange gain (loss)		10,664		(3,198)		(464)
Income from equity method investments, net		2,505		12,389		1,796
Other income, net		4,242		18,466		2,677
Loss before income tax expenses		(6,034)		(60,553)		(8,779)
Income tax benefits (expenses)		433		(1,375)		(199)
Net loss		(5,601)		(61,928)		(8,978)
Net loss attributable to non-controlling interests and redeemable non- controlling interests		298		1,414		205
Net loss attributable to Yatsen's shareholders		(5,303)		(60,514)		(8,773)
Shares used in calculating loss per share (1):
Weighted average number of Class A and Class B ordinary shares:
Basic		1,837,466,068		1,876,901,662		1,876,901,662
Diluted		1,837,466,068		1,876,901,662		1,876,901,662
Net loss per Class A and Class B ordinary share
Basic		(0.00)		(0.03)		(0.00)
Diluted		(0.00)		(0.03)		(0.00)
Net loss per ADS (20 ordinary shares equal to 1 ADS) (2)
Basic		(0.06)		(0.64)		(0.09)
Diluted		(0.06)		(0.64)		(0.09)

	For the Three Months Ended March 31,
	2025		2026		2026
Share-based compensation expenses are included in the operating expenses as follows:	RMB'000		RMB'000		USD'000
Fulfilment expenses		98		249		36
Selling and marketing expenses		757		148		21
General and administrative expenses		7,731		2,003		290
Research and development expenses		40		1,159		168
Total		8,626		3,559		515

(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that are subject to shareholder vote.

YATSEN HOLDING LIMITED
UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS
(All amounts in thousands, except for share, per share data or otherwise noted)

	For the Three Months Ended March 31,
	2025		2026		2026
	RMB'000		RMB'000		USD'000
Loss from operations		(34,051)		(98,951)		(14,345)
Share-based compensation expenses		8,626		3,559		515
Amortization of intangible assets resulting from assets and business acquisitions		10,561		10,759		1,560
Non-GAAP loss from operations		(14,864)		(84,633)		(12,270)
Net loss		(5,601)		(61,928)		(8,978)
Share-based compensation expenses		8,626		3,559		515
Amortization of intangible assets resulting from assets and business acquisitions		10,561		10,759		1,560
Revaluation of investments on the share of equity method investments		(6,010)		(10,469)		(1,518)
Tax effects on non-GAAP adjustments		(433)		829		120
Non-GAAP net income (loss)		7,143		(57,250)		(8,301)
Net loss attributable to Yatsen's shareholders		(5,303)		(60,514)		(8,773)
Share-based compensation expenses		8,626		3,559		515
Amortization of intangible assets resulting from assets and business acquisitions		10,179		10,473		1,518
Revaluation of investments on the share of equity method investments		(6,010)		(10,469)		(1,518)
Tax effects on non-GAAP adjustments		(405)		829		120
Non-GAAP net income (loss) attributable to Yatsen's shareholders		7,087		(56,122)		(8,138)
Shares used in calculating loss per share:
Weighted average number of Class A and Class B ordinary shares:
Basic		1,837,466,068		1,876,901,662		1,876,901,662
Diluted		1,953,491,427		1,876,901,662		1,876,901,662
Non-GAAP net income (loss) attributable to ordinary shareholders per Class A and Class B ordinary share
Basic		0.00		(0.03)		(0.00)
Diluted		0.00		(0.03)		(0.00)
Non-GAAP net income (loss) attributable to ordinary shareholders per ADS (20 ordinary shares equal to 1 ADS) (1)
Basic		0.08		(0.60)		(0.09)
Diluted		0.07		(0.60)		(0.09)

View original content:https://www.prnewswire.com/news-releases/yatsen-announces-first-quarter-2026-financial-results-302781575.html

SOURCE Yatsen Holding Limited

Yatsen Announces First Quarter 2026 Financial Results